Mrena J - Search Results

1

Prognostic significance of cyclin A in gastric cancer.

Mrena J, Wiksten JP, Kokkola A, Nordling S, Haglund C, Ristimäki A. Mrena J, et al. Int J Cancer. 2006 Oct 15;119(8):1897-901. doi: 10.1002/ijc.21944. Int J Cancer. 2006. PMID: 16708383

2

Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

Mrena J, Wiksten JP, Thiel A, Kokkola A, Pohjola L, Lundin J, Nordling S, Ristimäki A, Haglund C. Mrena J, et al. Clin Cancer Res. 2005 Oct 15;11(20):7362-8. doi: 10.1158/1078-0432.CCR-05-0764. Clin Cancer Res. 2005. PMID: 16243808

3

MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.

Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimäki A, Haglund C. Mrena J, et al. J Clin Pathol. 2006 Jun;59(6):618-23. doi: 10.1136/jcp.2005.033761. J Clin Pathol. 2006. PMID: 16731602 Free PMC article.

4

Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.

Linder N, Haglund C, Lundin M, Nordling S, Ristimäki A, Kokkola A, Mrena J, Wiksten JP, Lundin J. Linder N, et al. Among authors: mrena j. J Clin Pathol. 2006 Sep;59(9):965-71. doi: 10.1136/jcp.2005.032524. J Clin Pathol. 2006. PMID: 16935971 Free PMC article.

5

15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.

Thiel A, Ganesan A, Mrena J, Junnila S, Nykänen A, Hemmes A, Tai HH, Monni O, Kokkola A, Haglund C, Petrova TV, Ristimäki A. Thiel A, et al. Among authors: mrena j. Clin Cancer Res. 2009 Jul 15;15(14):4572-80. doi: 10.1158/1078-0432.CCR-08-2518. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584167

6

COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer.

Mrena J, Wiksten JP, Kokkola A, Nordling S, Ristimäki A, Haglund C. Mrena J, et al. Tumour Biol. 2010 Jan;31(1):1-7. doi: 10.1007/s13277-009-0001-4. Epub 2009 Dec 18. Tumour Biol. 2010. PMID: 20237896

7

MMP-7 overexpression is an independent prognostic marker in gastric cancer.

Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagström J, Haglund C. Koskensalo S, et al. Among authors: mrena j. Tumour Biol. 2010 Jun;31(3):149-55. doi: 10.1007/s13277-010-0020-1. Epub 2010 Mar 19. Tumour Biol. 2010. PMID: 20300917

8

Cyclooxygenase-2 and gastric cancer.

Thiel A, Mrena J, Ristimäki A. Thiel A, et al. Among authors: mrena j. Cancer Metastasis Rev. 2011 Dec;30(3-4):387-95. doi: 10.1007/s10555-011-9312-1. Cancer Metastasis Rev. 2011. PMID: 22002749 Review.

9

Immunophenotype based on inflammatory cells, PD-1/PD-L1 signalling pathway and M2 macrophages predicts survival in gastric cancer.

Junttila A, Helminen O, Väyrynen JP, Ahtiainen M, Kenessey I, Jalkanen S, Mecklin JP, Kellokumpu I, Kuopio T, Böhm J, Mrena J. Junttila A, et al. Among authors: mrena j. Br J Cancer. 2020 Nov;123(11):1625-1632. doi: 10.1038/s41416-020-01053-7. Epub 2020 Sep 18. Br J Cancer. 2020. PMID: 32943749 Free PMC article.

10

Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.

Mrena J, Mattila A, Böhm J, Jantunen I, Kellokumpu I. Mrena J, et al. World J Gastroenterol. 2015 Dec 21;21(47):13294-301. doi: 10.3748/wjg.v21.i47.13294. World J Gastroenterol. 2015. PMID: 26715812 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page